Mind Medicine (MindMed) Inc N.MMED.WR

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Looks like major volume today! Nice MMED

<< Previous

Bullboard Posts

Next >>

Post by MrVerbatim9800on Jan 21, 2021 9:59am

295 Views

Post# 32343815

Looks like major volume today! Nice MMED

We have lowered our float over the last few months while week hands tucked and ran..... Solid shareholders, solid uptrend on the way. Signals are peaking through for NASDAQ uplist. "Consistant trading at $4.00 or above for the 30 days immediately preceeding the uplist".

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?